Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Human Vaccines|June 19, 2009
Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccineMichael Zinke, Rudolf Kappes, Klaus Kindler, et al.Vaccine|October 26, 2024
A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical studyElke Jordan, Victoria Jenkins, Günter Silbernagl, et al.British Journal of Anaesthesia|December 28, 2020
Propofol plus low-dose dexmedetomidine infusion and postoperative delirium in older patients undergoing cardiac surgeryMona Momeni, Céline Khalifa, Guillaume Lemaire, et al.Vaccine|November 20, 2021
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020Gerald Voss, Jeanne-Marie Jacquet, Nadia Tornieporth, et al.Journal of Cardiothoracic and Vascular Anesthesia|October 7, 2011
An increase in endogenous erythropoietin concentrations has no cardioprotective effects in patients undergoing coronary artery bypass graft surgeryMona Momeni, Giuseppe Liistro, Philippe Baele, et al.Journal of Cardiothoracic and Vascular Anesthesia|September 22, 2012
Fibrinogen concentration significantly decreases after on-pump versus off-pump coronary artery bypass surgery: a systematic point-of-care ROTEM analysisMona Momeni, Cécile Carlier, Philippe Baele, et al.The Pediatric Infectious Disease Journal|September 29, 2006
Antibody persistence after primary vaccination with a hexavalent DTPa-HBV-IPV/HiB vaccine coadministered with a meningococcal C-CRM197 vaccine and response to a DTPa-IPV/HiB booster at 18 months of ageJuan-Carlos Tejedor, Félix Omeñaca, José García-Sicilia, et al.Human Vaccines & Immunotherapeutics|March 28, 2022
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of ageAnna Lisa Ong-Lim, Georgi Shukarev, Mitzi Trinidad-Aseron, et al.The Pediatric Infectious Disease Journal|July 29, 2006
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccineJuan C Tejedor, Manuel Moro, Jesus Ruiz-Contreras, et al.The Pediatric Infectious Disease Journal|January 2, 2007
Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 monthsJuan C Tejedor, Manuel Moro, Jesús Ruiz-Contreras, et al.Pageof 6